Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2025

Antidilutive Securities Excluded from Computation of Earnings Per Share

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive are as follows:


	June 30, 2025		June 30, 2024
	(shares)		(shares)
Warrants to purchase shares of common stock		9,704,430		9,426,853
Options to purchase shares of common stock		7,541,818		7,369,758
Restricted stock units		496,520		408,000
Shares of common stock issuable upon conversion of convertible notes payable – related party		7,327,374		6,721,188
Shares of common stock issuable upon conversion of convertible line of credit – related party		29,621,834		21,016,837
Shares of common stock issuable upon conversion of preferred stock		495,007		499,174
		55,186,983		45,441,810